Revvity Inc（RVTY）の株式分析RVTYRevvity Inc

Revvity, Inc. provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. It has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards life sciences customers. The segment offers instruments, reagents, software, subscriptions, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the areas of reproductive health and emerging market diagnostics. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Revvity Inc is a good buy right now due to its current price of $128.80, which is below the analyst price target of $130, indicating potential upside. Additionally, the company has shown a strong year-to-date change of +31.23% and a solid gross margin of 57.13% in Q2 2026, suggesting robust profitability. However, the main risk is the recent decline in net profit to $51.82 million, down from $53.95 million, which could impact investor confidence.